Frequency and Clinical Correlates of JAK2 46/1 (GGCC) Haplotype in Primary Myelofibrosis

Leukemia - United Kingdom
doi 10.1038/leu.2010.126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The JAK2 46/1 (GGCC ) MPN-Predisposing Haplotype: A Risky Haplotype, After All

American Journal of Hematology
Hematology
2018English

The Role of the JAK2 GGCC Haplotype and the TET2 Gene in Familial Myeloproliferative Neoplasms

Haematologica
Hematology
2010English

SF3B1 Mutations in Primary Myelofibrosis: Clinical, Histopathology and Genetic Correlates Among 155 Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Driver Mutation‐Specific Clinical and Genomic Correlates Differ Between Primary and Secondary Myelofibrosis

American Journal of Hematology
Hematology
2019English

Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications

Oncologist
Cancer ResearchMedicineOncology
2015English

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Prefibrotic Versus Overtly Fibrotic Primary Myelofibrosis: Clinical, Cytogenetic, Molecular and Prognostic Comparisons

British Journal of Haematology
Hematology
2017English

Morphologic and Cytogenetic Differences Between Post-Polycythemic Myelofibrosis and Primary Myelofibrosis in Fibrotic Stage

Modern Pathology
Forensic MedicinePathology
2013English

Sensitive PCR-based Monitoring and Early Detection of Relapsed JAK2 V617F Myelofibrosis Following Transplantation

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy